New Analysis Links Wegovy to a Rare Eye Condition That Can Cause Sudden, Permanent Vision Loss A new analysis of more than 30 million FDA adverse event reports has found that Wegovy the higher-dose version of semaglutide used specifically for weight loss carries a meaningfully stronger safety signal for a rare eye condition than other semaglutide formulations, including Ozempic
GLP-1 medications improve glucose control and reduce systemic inflammation, which may reduce glycation stress on collagen
Diabetic patients using Ozempic might experience additional benefits from improved blood sugar control
Prostaglandins are chemicals that promote inflammation, pain, and fever, but also protect the stomach lining by stimulating mucus and bicarbonate production
When reduced glutathione performs this neutralization reaction with ROS, reduced glutathione itself becomes oxidized, which yields the oxidized form of glutathione known as GSSG